Influence of age on the clinical presentation of prolactinomas in male patients

Gerontology

Volumn 45, Issue 3, 1999, Pages 160-164

  Delgrange, Etienne ^a   Maiter, Dominique ^b   Donckier, Julian ^a   Tourniaire, Jacques ^c  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^b Hôpital Saint Luc   (Belgium)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Age; Dopamine agonists; Hypopituitarism; Prolactin secreting adenoma

Indexed keywords

BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; HYDROCORTISONE; PROLACTIN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DELAYED PUBERTY; ENDOCRINE FUNCTION TEST; GALACTORRHEA; GYNECOMASTIA; HEADACHE; HUMAN; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; HYPOTHYROIDISM; IMPOTENCE; LETHARGY; MALE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; RETROSPECTIVE STUDY; TUMOR VOLUME; VERTEBRA FRACTURE; VISUAL FIELD DEFECT;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; AGING; DOPAMINE AGONISTS; ERGOLINES; HUMANS; HYPOPITUITARISM; LUTEINIZING HORMONE; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; TESTOSTERONE;

EID: 0032953323     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022079     Document Type: Article

References (20)

1. Mindermann T, Wilson CB: Age-related and gender-relaled occurrence of pituitary adenomas. Clin Endocrinol (Oxf) 1994;41:359-364.
2. Benbow SJ, Foy P, Jones B, Shaw D, MacFarlane IA: Pituitary tumours presenting in the elderly: Management and outcome. Clin Endocrinol (Oxf) 1997;46:657-660.
3. Godfrey JB, Caird FI: Intracranial tumours in the elderly: Diagnosis and treatment. Age Ageing 1984;13:152-158.
4. Turner HE, Wass JAH: Pituitary tumours in the elderly. Baillières Clin Endocrinol Metab 1997;11:407-422.
5. Puchner MJA, Knappe UJ, Lüdecke DK: Pituitary surgery in elderly patients with acromegaly. Neurosurgery 1995;36:677-684.
6. Cohen DL, Bevan JS, Adams CBT: The presentation and management of pituitary tumours in the elderly. Age Ageing 1989;18:247-252.
7. Delgrange E, Trouillas J, Maiter D, Donckier J, Tourniaire J: Sex-related difference in the growth of prolactinomas: A clinical and proliferation marker study. J Clin Endocrinol Metab 1997;82:2102-2107.
8. Hulting AL, Muhr C, Lundberg PO, Werner S: Prolactinomas in men: Clinical characteristics and the effect of bromocriptine treatment. Acta Med Scand 1985;217:101-109.
9. Hägg E, Asplund K, Lithner F: Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency. Clin Endocrinol (Oxf) 1987;26:221-226.
10. Tayal SC, Bansal SK, Chadha DK: Hypopituitarism: A difficult diagnosis in elderly people but worth a search. Age Ageing 1994;23:320-322.
11. Johnston S, Hoult S, Chan CA: Falling again. Lancet 1996;348:26.
12. Belchetz PE: Idiopathic hypopituitarism in the elderly. Br Med J 1985;291:247-248.
13. Taylor SD, Kelly TM: Prolactinoma in a middle-aged man with an osteoporotic fracture. West J Med 1989;151:80-82.
14. Jackson JA, Kleerekoper M, Parfitt AM: Symptomatic osteoporosis in a man with hyperprolactinemic hypogonadism. Ann Intern Med 1986;105:543-545.
15. Greenspan SL, Neer RM, Ridgway EC, Klibanski A: Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med 1986;104:777-782.
16. Honegger J, Buchfelder M, Schrell U, Adams EF, Fahlbusch R: The coexistence of pituitary adenomas and meningiomas: Three case reports and a review of the literature. Br J Neurosurg 1989;3:59-69.
17. Muccioli G, Ghè C, Faccani G, Lanotte M, Forni M, Ciccarelli E: Prolactin receptors in human meningiomas: Characterization and biological role. J Endocrinol 1997;153:365-371.
18. Ferrari CI, Abs R, Bevan JS, Braban G, Ciccarelli E, Motta T, Mucci M, Muratori M, Musatti L, Verbessem G, Scanlon MF: Treatment of macroprolactinoma with cabergoline: A study of 85 patients. Clin Endocrinol (Oxf) 1997;46: 409-413.
19. Colao A, Di Sarno A, Sarnacchiaro F, Ferone D, Di Renzo G, Merola B, Annunziato L, Lombardi G: Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment. J Clin Endocrinol Metab 1997;82:876-883.
20. Delgrange E, Donckier J: Prolactinomas apparently resistant to quinagolide respond to cabergoline therapy. J Clin Endocrinol Metab 1997; 82:2755-2756.